Performant Healthcare to Report Fourth Quarter 2024 Earnings: A Look into the Company's Growth and Strategic Positioning

Performant Healthcare, Inc. (NASDAQ: PHLT), a leading provider of technology-enabled payment integrity, eligibility, and related analytics services, has announced that it will report its fourth quarter 2024 earnings after the market closes on Wednesday, March 12, 2025. The company will also host a conference call to discuss the results at 5:00 pm (Eastern Time) that day. Investors can access the call by dialing 800-717-1738 or 646-307-1865, or via a live webcast through the company's website. A replay will be available approximately three hours after the call using passcode 1173286.

Performant Healthcare's financial performance has evolved over the past few years, with trends observed in their revenue and earnings. In 2023, the company's revenue was $113.74 million, an increase of 4.18% compared to the previous year's $109.18 million. However, the company also reported losses of -$7.52 million in 2023, which was 15.0% more than in 2022. This indicates a mixed financial performance, with revenue growth but also an increase in losses.

The key drivers of Performant Healthcare's growth include advanced technology and analytics, expansion into new markets, strategic acquisitions and partnerships, commitment to quality and continuous improvement, and adaptability to economic conditions. By leveraging advanced technology and analytics, the company supports healthcare payers in identifying, preventing, and recovering waste and improper payments. This has been a significant driver of growth, as it enables the company to provide valuable services to healthcare payers, both government and commercial.

Performant Healthcare's strategy of focusing on payment integrity and analytics services positions it uniquely in the competitive landscape of the healthcare industry. By leveraging advanced technology, analytics, and proprietary data assets, the company supports healthcare payers in identifying, preventing, and recovering waste and improper payments. This specialized approach sets Performant apart from competitors and allows it to provide valuable services to both government and commercial healthcare markets.

Performant's services include coordination-of-benefits (COB) and claims-based auditing, which help healthcare payers mitigate future instances of improper payments. The company's advanced reporting capabilities, support services, customer care, and stakeholder training programs further enhance its value proposition. By focusing on these services, Performant has become a leading provider in both government and commercial healthcare markets, demonstrating its commitment to excellence and continuous improvement, as evidenced by its achievement of CMMI Maturity Level 3.

Performant's strategic shift to healthcare, as indicated by its name change to Performant Healthcare, Inc., reflects its dedication to the healthcare industry and its payment integrity and analytics services. This focus has enabled the company to participate in various investor conferences, such as the Upcoming Oppenheimer Emerging Growth Conference, the Upcoming BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference, and the Noble Capital Markets 20th Annual Emerging Growth Equity Conference, showcasing its commitment to growth and engagement with investors.

In conclusion, Performant Healthcare's upcoming earnings report provides an opportunity for investors to assess the company's financial performance and strategic positioning in the competitive landscape of the healthcare industry. The company's focus on payment integrity and analytics services, driven by advanced technology and a commitment to quality and continuous improvement, has positioned it as a key player in the healthcare industry. As the company reports its fourth quarter 2024 earnings, investors will gain valuable insights into its growth and strategic direction, enabling them to make informed investment decisions.

Word count: 598